A. Saltzman
Research Subjects
A. Saltzman has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Asher Zilberstein
Aventis Pharmaceuticals, Bridgewater, NJ 08887, USA
1 shared publication - Charles Epstein
Aventis Pharmaceuticals, Bridgewater, NJ 08887, USA
1 shared publication - Craig DeLoughery
Aventis Pharmaceuticals, Bridgewater, NJ 08887, USA
1 shared publication F Lieben
1 shared publication- Fan Long
Aventis Pharmaceuticals, Bridgewater, NJ 08887, USA
1 shared publication - Hong Liu
Aventis Pharmaceuticals, Bridgewater, NJ 08887, USA
1 shared publication
Latest Publications
- 1 September 2004
- Published by Springer Nature in Inflammation Research
- Vol. 53 (9) , 424-441
Understanding human dendritic cell biology through gene profiling
Dendritic cells are potent antigen presenting cells whose function has been associated with a variety of immunological disorders. Because of their relevance to human disease, extensive efforts have been made to gain a better understanding of their biology. One aspect of these efforts has been in the identification of pertinent molecules expressed in these cells through gene profiling experiments and proteomics. In this review, we summarize the results from the various profiling studies that have been done with human dendritic cells. We focus on molecules, which have been confirmed by other methods, such as quantitative PCR, or have been identified in multiple profiling studies to be expressed in the respective dendritic cell type. Through such profiling experiments and subsequent analysis, interesting molecules have been identified which can be further studied to determine their role in dendritic cell biology.
- 1 September 2004
- Published by Springer Nature in Inflammation Research
- Vol. 53 (9) , 424-441
Understanding human dendritic cell biology through gene profiling
Dendritic cells are potent antigen presenting cells whose function has been associated with a variety of immunological disorders. Because of their relevance to human disease, extensive efforts have been made to gain a better understanding of their biology. One aspect of these efforts has been in the identification of pertinent molecules expressed in these cells through gene profiling experiments and proteomics. In this review, we summarize the results from the various profiling studies that have been done with human dendritic cells. We focus on molecules, which have been confirmed by other methods, such as quantitative PCR, or have been identified in multiple profiling studies to be expressed in the respective dendritic cell type. Through such profiling experiments and subsequent analysis, interesting molecules have been identified which can be further studied to determine their role in dendritic cell biology.
- Open Access
- 27 April 2004
- Published by Springer Nature in BMC Genomics
- Vol. 5 (1) , 26
Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study
Several high throughput technologies have been employed to identify differentially regulated genes that may be molecular targets for drug discovery. Here we compared the sets of differentially regulated genes discovered using two experimental approaches: a subtracted suppressive hybridization (SSH) cDNA library methodology and Affymetrix GeneChip technology. In this "case study" we explored the transcriptional pattern changes during the in vitro differentiation of human monocytes to myeloid dendritic cells (DC), and evaluated the potential for novel gene discovery using the SSH methodology. The same RNA samples isolated from peripheral blood monocyte precursors and immature DC (iDC) were used for GeneChip microarray probing and SSH cDNA library construction. 10,000 clones from each of the two-way SSH libraries (iDC-monocytes and monocytes-iDC) were picked for sequencing. About 2000 transcripts were identified for each library from 8000 successful sequences. Only 70% to 75% of these transcripts were represented on the U95 series GeneChip microarrays, implying that 25% to 30% of these transcripts might not have been identified in a study based only on GeneChip microarrays. In addition, about 10% of these transcripts appeared to be "novel", although these have not yet been closely examined. Among the transcripts that are also represented on the chips, about a third were concordantly discovered as differentially regulated between iDC and monocytes by GeneChip microarray transcript profiling. The remaining two thirds were either not inferred as differentially regulated from GeneChip microarray data, or were called differentially regulated but in the opposite direction. This underscores the importance both of generating reciprocal pairs of SSH libraries, and of real-time RT-PCR confirmation of the results. This study suggests that SSH could be used as an alternative and complementary transcript profiling tool to GeneChip microarrays, especially in identifying novel genes and transcripts of low abundance.
- 27 April 2004
- Published by Springer Nature in BMC Genomics
- Vol. 5 (1) , 26
Open AccessComparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study
Several high throughput technologies have been employed to identify differentially regulated genes that may be molecular targets for drug discovery. Here we compared the sets of differentially regulated genes discovered using two experimental approaches: a subtracted suppressive hybridization (SSH) cDNA library methodology and Affymetrix GeneChip technology. In this "case study" we explored the transcriptional pattern changes during the in vitro differentiation of human monocytes to myeloid dendritic cells (DC), and evaluated the potential for novel gene discovery using the SSH methodology. The same RNA samples isolated from peripheral blood monocyte precursors and immature DC (iDC) were used for GeneChip microarray probing and SSH cDNA library construction. 10,000 clones from each of the two-way SSH libraries (iDC-monocytes and monocytes-iDC) were picked for sequencing. About 2000 transcripts were identified for each library from 8000 successful sequences. Only 70% to 75% of these transcripts were represented on the U95 series GeneChip microarrays, implying that 25% to 30% of these transcripts might not have been identified in a study based only on GeneChip microarrays. In addition, about 10% of these transcripts appeared to be "novel", although these have not yet been closely examined. Among the transcripts that are also represented on the chips, about a third were concordantly discovered as differentially regulated between iDC and monocytes by GeneChip microarray transcript profiling. The remaining two thirds were either not inferred as differentially regulated from GeneChip microarray data, or were called differentially regulated but in the opposite direction. This underscores the importance both of generating reciprocal pairs of SSH libraries, and of real-time RT-PCR confirmation of the results. This study suggests that SSH could be used as an alternative and complementary transcript profiling tool to GeneChip microarrays, especially in identifying novel genes and transcripts of low abundance.
- 1 May 1950
- Vol. 17 (1) , 21-5
Urinary excretion of stilbamidine and 2-hydroxystilbamidine.